Post-Publication Discussion

Pharmatera Journal is committed to maintaining the accuracy, transparency, and integrity of the scientific literature by encouraging constructive academic discussion and critical evaluation of published articles. The journal recognizes that scholarly communication continues beyond publication and that post-publication discussion plays an essential role in advancing scientific knowledge and improving research quality.

In accordance with the ethical principles and guidelines established by the Committee on Publication Ethics (COPE), Pharmatera Journal provides opportunities for readers, researchers, authors, and other members of the academic community to raise questions, provide comments, and discuss the findings of published articles.

1. Purpose of Post-Publication Discussion

Post-publication discussion aims to promote scientific transparency, encourage constructive criticism, facilitate academic dialogue, and maintain the reliability of published research.

Pharmatera Journal welcomes scientifically grounded discussions concerning research methodologies, data interpretation, findings, conclusions, and other relevant aspects of published articles.

All discussions must be conducted professionally, respectfully, and in accordance with established principles of academic integrity.

2. Submission of Comments and Discussions

Readers, researchers, and other interested parties may submit comments, questions, or concerns regarding articles published in Pharmatera Journal through the journal's official editorial communication channels.

Submissions should include clear identification of the article being discussed, a description of the issue or concern, and relevant scientific evidence or supporting references.

The Editorial Board will assess submitted comments to determine their relevance, scientific validity, and suitability for further consideration.

Comments containing personal attacks, discriminatory language, unsupported allegations, or inappropriate content will not be considered for publication.

3. Author Responses

Authors of published articles may be invited to respond to questions, comments, or criticisms raised during post-publication discussions.

Authors are expected to provide clear, evidence-based explanations and respond professionally to legitimate scientific concerns.

When necessary, authors may be requested to provide additional methodological information, supporting documentation, or clarification regarding their published findings, subject to applicable ethical and confidentiality requirements.

4. Editorial Evaluation

The Editorial Board is responsible for ensuring that post-publication discussions remain objective, constructive, and scientifically relevant.

Editors may consult independent experts or peer reviewers when evaluating technical or methodological concerns.

Where appropriate, scientifically relevant comments and author responses may be published as formal correspondence, editorial notices, or other suitable forms of scholarly communication.

Editorial decisions will be based on the scientific merit of the discussion and the need to maintain the integrity of the published record.

5. Corrections and Clarifications

If post-publication discussion identifies errors, inaccuracies, or omissions in a published article, Pharmatera Journal will evaluate whether corrective action is necessary.

Minor errors that do not affect the reliability of the research findings may be addressed through a formal correction or clarification.

Corrections will be clearly identified and linked to the original article whenever applicable to ensure transparency and accessibility for readers.

6. Expressions of Concern and Retractions

When post-publication discussions raise credible concerns regarding research integrity, data reliability, plagiarism, or other serious publication ethics issues, Pharmatera Journal will initiate an appropriate editorial assessment in accordance with COPE guidance.

Depending on the findings, the journal may take the following actions:

  1. Expression of Concern: Published when significant concerns about the reliability or integrity of an article remain unresolved.

  2. Correction: Issued when errors can be corrected without invalidating the overall scientific findings.

  3. Retraction: Issued when substantial errors, unreliable findings, or serious ethical violations make the article unsuitable for continued inclusion in the scientific record without a retraction notice.

Authors will be given an appropriate opportunity to respond to allegations or concerns before editorial action is finalized.

7. Transparency and Ethical Conduct

Pharmatera Journal is committed to ensuring that post-publication discussions are conducted fairly, transparently, and without discrimination.

All participants must respect academic integrity, confidentiality, intellectual property rights, and professional standards of scholarly communication.

Potential conflicts of interest related to submitted comments or responses must be disclosed.

The Editorial Board reserves the right to moderate discussions and reject contributions that do not meet the journal's ethical and scientific standards.

8. Commitment to Scientific Integrity

Pharmatera Journal recognizes post-publication discussion as an important component of scientific progress and responsible scholarly publishing.

The journal encourages constructive engagement among authors, readers, reviewers, and researchers to support continuous scientific evaluation and improvement.

By facilitating responsible academic dialogue and addressing legitimate concerns about published research, Pharmatera Journal aims to maintain the credibility, reliability, and integrity of the scientific literature.

Reference:

Committee on Publication Ethics (COPE): https://publicationethics.org/